Drug Evaluation Committee OSS Usage Questionnaire Report for FY2024
Data Science Subcommittee
January 2025
We have compiled the results of a survey on the use of open source software (OSS), "R", in clinical development work among member companies of the Data Science Committee and its discussion in the "FY2024 OSS Usage Questionnaire Report".
The results of the survey show the current status of how "R" is being used in clinical development work, changes from a similar survey conducted two years ago, and what each company expects and considers to be issues.
We hope that this report will help you consider the use of open source software, especially R, in your company.
Japan Pharmaceutical Manufacturers Association, Committee on Drug Evaluation
Data Science Subcommittee FY2024 Continuing Task Force 11
OSS Usage Questionnaire Report for FY2024
Deliverables of the Drug Evaluation Committee Return to list of all deliverables